Katie Lee March 27 2019 Health Canada releases further information alongside Action Plan on Medical Devices Smart & Biggar | Healthcare & Life Sciences - Canada Katie Lee Healthcare & Life Sciences Further to Health Canada's Action Plan on Medical Devices, it has also released the following:Health Canada's Action Plan on Medical Devices: Continuously Improving Safety, Effectiveness and Quality – Informing Canadians about medical device treatment options – further to Part III of the Action Plan on Medical Devices, Health Canada has begun to publish Regulatory Decision Summaries for Class III medical device licences (eg, orthopaedic implants and blood glucose monitors) starting 31 January 2019 on Health Canada's Drug and Health Product Register.Scientific Advisory Committee on Medical Devices Used in the Cardiovascular System – announcement of meeting, 1 March 2019 – on 1 February 2019 Health Canada issued a notice announcing an upcoming meeting of Health Canada's Scientific Advisory Committee on Medical Devices used in the Cardiovascular System. Health Canada stated that advice received from this meeting will be used to facilitate and enhance the review process for medical devices used in the cardiovascular system.Scientific Advisory Committee on Health Products for Women (SAC-HPW): nomination call for members – on 30 January 2019 Health Canada published a nomination call for members for an SAC-HPW. The SAC-HPW will provide advice on issues regarding women's health and the regulation of medical devices and drugs.Consultation on Draft Guidance Document for Software as a Medical Device – Health Canada has developed the draft guidance to better define regulatory compliance requirements for emerging technologies. Consultation on the draft guidance document closed on 29 March 2019.For further information on this topic please contact Katie Lee at Smart & Biggar/Fetherstonhaugh by telephone (+1 416 593 5514) or email ([email protected]). The Smart & Biggar/Fetherstonhaugh website can be accessed at www.smart-biggar.ca.